Post-treatment changes in bowel and urinary function in prostate cancer patients treated with moderate or ultra-hypofractionation: A prospective cohort study
We assessed post-treatment changes in HRQoL in a clinical PCa patient population treated with MHF and UHF, and observed changes comparable to previous trial reports. Deteriorations in bowel and urinary function correlated with worse general health scores. Results for urinary function loss suggested a consequential effect of acute urinary toxicity.
Authors
- M Franckena
- Wilma D. Heemsbergen (ORCID: https://orcid.org/0000-0003-2144-0729)
- Femke E. Froklage
- Kim C. de Vries
- Felix Sinzabakira (ORCID: https://orcid.org/0000-0001-6544-5842)
- Miranda E.M.C. Christianen
- Luca Incrocci (ORCID: https://orcid.org/0000-0001-9994-763X)
- Henrike Westerveld
Institutions
- Erasmus MC Cancer Institute (NL)
Publication Details
- Journal
- Clinical and Translational Radiation Oncology
- Published
- 2025-04-08
- DOI
- https://doi.org/10.1016/j.ctro.2025.100955
- Citations
- 2
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.04